Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.34 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10538294 | 0.88 | — | — | |
| SCHEMBL10537828 | 0.85 | ADRA2A (0.30) | ADRA2AADRA2BADRA2C | |
| SCHEMBL6576319 | 0.83 | ADRA2A (0.31) | ADRA2AADRA2BADRA2C | |
| SCHEMBL377055 | 0.81 | ADRA2A (0.36) | ADRA2AADRA2BADRA2C | |
| SCHEMBL8100084 | 0.78 | ADRA2A (0.32) | ADRA2AADRA2BADRA2C | |
| SCHEMBL377286 | 0.76 | ADRA2A (0.38) | ADRA2AADRA2BADRA2C | |
| SCHEMBL12719609 | 0.75 | LMNA (0.31) | ADRA2AADRA2BADRA2C | |
| SCHEMBL23466952 | 0.74 | ADH1B (0.33) | ADRA2AADRA2BADRA2C | |
| SCHEMBL8102055 | 0.72 | ADRA2A (0.33) | ADRA2AADRA2BADRA2C | |
| SCHEMBL10646498 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021027807-A1 | METHOD FOR PREPARING AZELAIC ACID | 新钰生技股份有限公司 | 2021-02-18 | — | — | WO | disclosed |
| US-20210047257-A1 | Process for preparing azelaic acid | CORUM INC. (TW) | 2021-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047257-A1 | Process for preparing azelaic acid | TTPA, OSGEP, AOC3 | ADRA2A 2036/4885ADRA2B 2255/4885ADRA2C 2494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.